These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 22673486

  • 1. Is botulinum toxin A effective for the treatment of plantar fasciitis?
    Peterlein CD, Funk JF, Hölscher A, Schuh A, Placzek R.
    Clin J Pain; 2012 Jul; 28(6):527-33. PubMed ID: 22673486
    [Abstract] [Full Text] [Related]

  • 2. Treatment of pain attributed to plantar fasciitis with botulinum toxin a: a short-term, randomized, placebo-controlled, double-blind study.
    Babcock MS, Foster L, Pasquina P, Jabbari B.
    Am J Phys Med Rehabil; 2005 Sep; 84(9):649-54. PubMed ID: 16141740
    [Abstract] [Full Text] [Related]

  • 3. Randomized controlled study of the efficacy of the injection of botulinum toxin type A versus corticosteroids in chronic plantar fasciitis: results at one and six months.
    Díaz-Llopis IV, Rodríguez-Ruíz CM, Mulet-Perry S, Mondéjar-Gómez FJ, Climent-Barberá JM, Cholbi-Llobel F.
    Clin Rehabil; 2012 Jul; 26(7):594-606. PubMed ID: 22144721
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of intra-articular botulinum toxin type A in painful knee osteoarthritis: a pilot study.
    Boon AJ, Smith J, Dahm DL, Sorenson EJ, Larson DR, Fitz-Gibbon PD, Dykstra DD, Singh JA.
    PM R; 2010 Apr; 2(4):268-76. PubMed ID: 20430328
    [Abstract] [Full Text] [Related]

  • 5. Botulinum toxin type A in chronic plantar fasciitis: clinical effects one year after injection.
    Díaz-Llopis IV, Gómez-Gallego D, Mondéjar-Gómez FJ, López-García A, Climent-Barberá JM, Rodríguez-Ruiz CM.
    Clin Rehabil; 2013 Aug; 27(8):681-5. PubMed ID: 23411793
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H, Heinze A, Reichel G, Hefter H, Benecke R, Dysport myofascial pain study group.
    Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group.
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [Abstract] [Full Text] [Related]

  • 8. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
    Benecke R, Heinze A, Reichel G, Hefter H, Göbel H, Dysport myofascial pain study group.
    Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of chronic plantar fasciitis with botulinum toxin A--an open pilot study on 25 patients with a 14-week-follow-up].
    Placzek R, Hölscher A, Deuretzbacher G, Meiss L, Perka C.
    Z Orthop Ihre Grenzgeb; 2006 Nov; 144(4):405-9. PubMed ID: 16941299
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ, Germanson T, Myobloc/Neurobloc European Cervical Dystonia Study Group.
    Mov Disord; 2008 Mar 15; 23(4):510-7. PubMed ID: 18098274
    [Abstract] [Full Text] [Related]

  • 11. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial.
    Wu CJ, Lian YJ, Zheng YK, Zhang HF, Chen Y, Xie NC, Wang LJ.
    Cephalalgia; 2012 Apr 15; 32(6):443-50. PubMed ID: 22492424
    [Abstract] [Full Text] [Related]

  • 12. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.
    Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C, BOTOX CDH Study Group.
    Headache; 2005 Apr 15; 45(4):293-307. PubMed ID: 15836565
    [Abstract] [Full Text] [Related]

  • 13. Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial.
    Singh JA, Mahowald ML, Noorbaloochi S.
    Transl Res; 2009 May 15; 153(5):205-16. PubMed ID: 19375681
    [Abstract] [Full Text] [Related]

  • 14. Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia.
    Truong D, Brodsky M, Lew M, Brashear A, Jankovic J, Molho E, Orlova O, Timerbaeva S, Global Dysport Cervical Dystonia Study Group.
    Parkinsonism Relat Disord; 2010 Jun 15; 16(5):316-23. PubMed ID: 20359934
    [Abstract] [Full Text] [Related]

  • 15. Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind study.
    Miller D, Richardson D, Eisa M, Bajwa RJ, Jabbari B.
    Pain Med; 2009 Sep 15; 10(6):1012-7. PubMed ID: 19594841
    [Abstract] [Full Text] [Related]

  • 16. Ultrasonographic guided botulinum toxin type A treatment for plantar fasciitis: an outcome-based investigation for treating pain and gait changes.
    Huang YC, Wei SH, Wang HK, Lieu FK.
    J Rehabil Med; 2010 Feb 15; 42(2):136-40. PubMed ID: 20140409
    [Abstract] [Full Text] [Related]

  • 17. The efficacy of oral nonsteroidal anti-inflammatory medication (NSAID) in the treatment of plantar fasciitis: a randomized, prospective, placebo-controlled study.
    Donley BG, Moore T, Sferra J, Gozdanovic J, Smith R.
    Foot Ankle Int; 2007 Jan 15; 28(1):20-3. PubMed ID: 17257533
    [Abstract] [Full Text] [Related]

  • 18. Comparison of extracorporeal shock wave therapy with botulinum toxin type A in the treatment of plantar fasciitis.
    Roca B, Mendoza MA, Roca M.
    Disabil Rehabil; 2016 Oct 15; 38(21):2114-21. PubMed ID: 26930375
    [Abstract] [Full Text] [Related]

  • 19. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr 15; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
    Truong D, Duane DD, Jankovic J, Singer C, Seeberger LC, Comella CL, Lew MF, Rodnitzky RL, Danisi FO, Sutton JP, Charles PD, Hauser RA, Sheean GL.
    Mov Disord; 2005 Jul 15; 20(7):783-91. PubMed ID: 15736159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.